Annemarie E. Engstrom

Learn More
OBJECTIVE The general population is gradually ageing in the western world. Therefore, the number of octogenarians undergoing primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) is increasing. We aim to provide insight into temporal trends in the annual proportions of octogenarians among STEMI patients undergoing(More)
Despite early revascularization, mortality remains high in patients with ST-segment elevation myocardial infarction (STEMI) complicated by cardiogenic shock. It has been shown that the effect of multivessel disease (MVD) on mortality in patients with STEMI treated with primary percutaneous coronary intervention is mainly caused by the presence of chronic(More)
BACKGROUND Recently, a chronic total occlusion (CTO) in a non-infarct-related artery (non-IRA) and not multivessel disease (MVD) alone was identified as an independent predictor of mortality after ST elevation myocardial infarction (STEMI). Patients with diabetes mellitus (DM) constitute a patient group with a high prevalence of MVD and high mortality after(More)
BACKGROUND In the present study we developed, evaluated in volunteers, and clinically validated an image acquisition stabilizer (IAS) for Sidestream Dark Field (SDF) imaging. METHODS The IAS is a stainless steel sterilizable ring which fits around the SDF probe tip. The IAS creates adhesion to the imaged tissue by application of negative pressure. The(More)
G. Balestra, Z.-Y. Yong, R. Bezemer, K. Sjauw, A. Engstrom, E. C. Boerma, C. Ince Department of Translational Physiology, Academic Medical Center at the University of Amsterdam, Amsterdam, The The Netherlands, Department of Internal Medicine and Medical Intensive Care Unit, University Hospital Basel, Basel, Switzerland, Department of Cardiology, Academic(More)
OBJECTIVES The aim of this study was to evaluate the effect of a concurrent chronic total occlusion (CTO) in patients with ST-segment elevation myocardial infarction (STEMI) on long-term mortality and left ventricular ejection fraction (LVEF). BACKGROUND The impact of a CTO in a non-infarct-related artery (IRA) on prognosis after STEMI is unknown. (More)
  • 1